18th September 2007 - Antitope Ltd., a leader in antibody and protein engineering, today announced a research agreement with Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer). Under the Agreement, Antitope will engineer a novel antibody developed by Fraunhofer to produce an improved therapy for the treatment of transplantation patients.
